Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications

Russell Collighan; Martin Griffin

doi:10.1007/s00726-008-0190-y

Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications

Research output: Contribution to journal › Article › peer-review

Abstract

This review summarises the functions of the enzyme tissue transglutaminase (TG2) in the extracellular matrix (ECM) both as a matrix stabiliser through its protein cross-linking activity and as an important cell adhesion protein involved in cell survival. The contribution of extracellular TG2 to the pathology of important diseases such as cancer and fibrosis are discussed with a view to the potential importance of TG2 as a therapeutic target. The medical applications of TG2 are further expanded by detailing the use of transglutaminase cross-linking in the development of novel biocompatible biomaterials for use in soft and hard tissue repair.

Original language	English
Pages (from-to)	659-670
Number of pages	12
Journal	Amino Acids
Volume	36
Issue number	4
DOIs	https://doi.org/10.1007/s00726-008-0190-y
Publication status	Published - Apr 2009

Bibliographical note

9th Conference on Transglutaminase and Protein Crosslinking, Marrakesh, Monaco, September 2007

Keywords

tissue transglutaminase
TG2
biomaterials
extracellular matrix
cross-linking

Access to Document

10.1007/s00726-008-0190-y

Cite this

@article{edfac88a657d4437992efe2abdc72f58,

title = "Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications",

abstract = "This review summarises the functions of the enzyme tissue transglutaminase (TG2) in the extracellular matrix (ECM) both as a matrix stabiliser through its protein cross-linking activity and as an important cell adhesion protein involved in cell survival. The contribution of extracellular TG2 to the pathology of important diseases such as cancer and fibrosis are discussed with a view to the potential importance of TG2 as a therapeutic target. The medical applications of TG2 are further expanded by detailing the use of transglutaminase cross-linking in the development of novel biocompatible biomaterials for use in soft and hard tissue repair.",

keywords = "tissue transglutaminase, TG2, biomaterials, extracellular matrix, cross-linking",

author = "Russell Collighan and Martin Griffin",

note = "9th Conference on Transglutaminase and Protein Crosslinking, Marrakesh, Monaco, September 2007",

year = "2009",

month = apr,

doi = "10.1007/s00726-008-0190-y",

language = "English",

volume = "36",

pages = "659--670",

journal = "Amino Acids",

issn = "0939-4451",

publisher = "Springer",

number = "4",

}

TY - JOUR

T1 - Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications

AU - Collighan, Russell

AU - Griffin, Martin

N1 - 9th Conference on Transglutaminase and Protein Crosslinking, Marrakesh, Monaco, September 2007

PY - 2009/4

Y1 - 2009/4

N2 - This review summarises the functions of the enzyme tissue transglutaminase (TG2) in the extracellular matrix (ECM) both as a matrix stabiliser through its protein cross-linking activity and as an important cell adhesion protein involved in cell survival. The contribution of extracellular TG2 to the pathology of important diseases such as cancer and fibrosis are discussed with a view to the potential importance of TG2 as a therapeutic target. The medical applications of TG2 are further expanded by detailing the use of transglutaminase cross-linking in the development of novel biocompatible biomaterials for use in soft and hard tissue repair.

AB - This review summarises the functions of the enzyme tissue transglutaminase (TG2) in the extracellular matrix (ECM) both as a matrix stabiliser through its protein cross-linking activity and as an important cell adhesion protein involved in cell survival. The contribution of extracellular TG2 to the pathology of important diseases such as cancer and fibrosis are discussed with a view to the potential importance of TG2 as a therapeutic target. The medical applications of TG2 are further expanded by detailing the use of transglutaminase cross-linking in the development of novel biocompatible biomaterials for use in soft and hard tissue repair.

KW - tissue transglutaminase

KW - TG2

KW - biomaterials

KW - extracellular matrix

KW - cross-linking

UR - http://www.scopus.com/inward/record.url?scp=62949217561&partnerID=8YFLogxK

UR - http://www.springerlink.com/content/283125vr04886127/?p=7f0b8defff6a4551899466477578e3db&pi=0

U2 - 10.1007/s00726-008-0190-y

DO - 10.1007/s00726-008-0190-y

M3 - Article

SN - 0939-4451

VL - 36

SP - 659

EP - 670

JO - Amino Acids

JF - Amino Acids

IS - 4

ER -

Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this